NCT06647810View on ClinicalTrials.gov

A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

December 12, 2024

Study Completion Date

January 7, 2025

Conditions
Healthy
Interventions
DRUG

BI 690517 formulation 1

BI 690517 formulation 1

DRUG

BI 690517 formulation 2

BI 690517 formulation 2

DRUG

Probenecid

Probenecid

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06647810 - A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood | Biotech Hunter | Biotech Hunter